159. Xeroderma pigmentosum Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 17 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 15
Xeroderma pigmentosum and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 159 | Xeroderma pigmentosum |
| 53 | Sjogren syndrome |
| 49 | Systemic lupus erythematosus |
| 96 | Crohn disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 39 | Toxic epidermal necrolysis |